N-(6-Acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide

Catalog No. :
ACNAIJ817
CAS No. :
460994-47-2
Molecular Formula :
C15H12BrNO5S
Molecular Weight :
398.23

IUPAC Name:N-(6-acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide

N-(6-Acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg95%$362.00Login to see priceInquiryInquiry
50mg95%$616.00Login to see priceInquiryInquiry
100mg95%$1045.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(6-Acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide
IUPAC NameN-(6-acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide
MDL No.MFCD03114921
Molecular FormulaC15H12BrNO5S
Molecular Weight398.23
SMILESO=S(C1=CC=CC=C1Br)(NC2=C(C(C)=O)C=C(OCO3)C3=C2)=O
InChI KeyNFOIEEPIYDXZNN-UHFFFAOYSA-N
SynonymBenzenesulfonamide, N-(6-acetyl-1,3-benzodioxol-5-yl)-2-bromo-;WAY-351783;N-(6-Acetylbenzo[d][1,3]dioxol-5-yl)-2-bromobenzenesulfonamide
CAS No.460994-47-2
PubChem CID1448335

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNAIJ817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBPRO081 route compound structure diagram
    ACBPRO08128657-75-2 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNAIJ817 route product structure diagram
    ACNAIJ817460994-47-2
Inquiry

2. ACNAIJ817 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNAIJ817 route product structure diagram
    ACNAIJ817460994-47-2
Inquiry

Comments (0)